Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in Korea.
Beom SH, Bae KB, Zang DY, Bae J, Hwang IG, Kang HJ, Woo IS, Shim BY, Bae BN, Cheon J, Oh SB, Ahn JB. Beom SH, et al. Among authors: bae bn. J Cancer. 2022 Sep 21;13(13):3396-3403. doi: 10.7150/jca.74107. eCollection 2022. J Cancer. 2022. PMID: 36313033 Free PMC article.
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen.
Beom SH, Kim JG, Baik SH, Shin SH, Park I, Park YS, Lee MA, Lee S, Jeon SY, Han SW, Kang MH, Oh J, Kim JS, Kim JY, Ahn MS, Zang DY, Bae BN, Jo HJ, Kim HK, Kim JH, Yoon JA, Kim DH. Beom SH, et al. Among authors: bae bn. J Cancer Res Clin Oncol. 2023 Mar;149(3):1131-1143. doi: 10.1007/s00432-022-03946-x. Epub 2022 Mar 27. J Cancer Res Clin Oncol. 2023. PMID: 35344080
Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW, Kang BM, Kim IY, Kim JY, Park SJ, Park WC, Bae KB, Bae BN, Baek SK, Baik SH, Son GM, Lee YS, Lee SH. Kim CW, et al. Among authors: bae kb, bae bn. BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7. BMC Cancer. 2018. PMID: 29739356 Free PMC article.
Analysis of the potent prognostic factors in luminal-type breast cancer.
Kim HS, Park I, Cho HJ, Gwak G, Yang K, Bae BN, Kim KW, Han S, Kim HJ, Kim YD. Kim HS, et al. Among authors: bae bn. J Breast Cancer. 2012 Dec;15(4):401-6. doi: 10.4048/jbc.2012.15.4.401. Epub 2012 Dec 31. J Breast Cancer. 2012. PMID: 23346168 Free PMC article.
41 results